Churchill Capital Corp XI
- Market cap
- 626.07M
- P/E (TTM)i
- 0.00
- P/Bi
- 2.33
- EPSi
- 0.00
- Div yieldi
- 0.00%
- 52W posi
- 12%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Shell Companies
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Churchill Capital Corp XI (CCXI) | 626.07M | 0.00 | 2.33 | 0.00% |
| Vylor Inc (VYLR) | 48.70B | 102.95 | 3.21 | 0.00% |
| ARMADA ACQUISITION CORP II (XRPN) | 790.07M | 252.63 | 3.49 | 0.00% |
| DRUGS MADE IN AMERICA ACQ II CORP (DMII) | 649.10M | 34.90 | 1.31 | 0.00% |
| EQV VENTURES ACQUISITION CORP. II (EVAC) | 602.60M | 14.75 | 1.31 | 0.00% |
| Bain Capital GSS Investment (BCSS) | 596.85M | 0.00 | 1.30 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 2.8% below Morningstar's fair value estimate.
Fair value
Churchill Capital Corp XI earns a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a minor 3% discount to our quantitative fair value estimate of $11.56 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's liquidity bolsters our fair value estimate. Adequate liquidity allows a company to meet short-term obligations, enhancing financial stability and reducing distress risk. For example, the firm's median trading volume over the past 60 days ranks in the top 30% compared with global peers. Trading volumes are high on shares, which may indicate increased institutional interest in stock ownership. We believe this is a sign that shares could be undervalued.
On a different note, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to market value ratio of 1.0, for example, sits in the bottom 45% globally. The market value of equity makes up a large fraction of enterprise value, indicating that shares have sharply risen, or that the company has a "lazy" balance sheet that is underleveraged. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.
Economic moat
With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-08 07:19:51 · For reference only, not investment advice and not tailored to your situation.